tradingkey.logo

BRIEF-Tiziana Announces Discovery Of New Immune Biomarkers In Multiple Sclerosis Patients Treated With Nasal Foralumab

ReutersJan 22, 2025 9:53 PM

- Tiziana Life Sciences Ltd TLSA.O:

  • TIZIANA LIFE SCIENCES ANNOUNCES DISCOVERY OF NEW IMMUNE BIOMARKERS IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH NASAL FORALUMAB

  • TIZIANA LIFE SCIENCES LTD - GENE EXPRESSION CHANGES DETECTED THREE MONTHS AFTER FORALUMAB DOSING

Source text: ID:nGNX6FqjN3

Further company coverage: TLSA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI